234 related articles for article (PubMed ID: 35553272)
1. Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.
Urzua CA; Herbort CP; Takeuchi M; Schlaen A; Concha-Del-Rio LE; Usui Y; Cuitino L; Papasavvas I
J Ophthalmic Inflamm Infect; 2022 May; 12(1):17. PubMed ID: 35553272
[TBL] [Abstract][Full Text] [Related]
2. Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.
Herbort CP; Tugal-Tutkun I; Abu-El-Asrar A; Gupta A; Takeuchi M; Fardeau C; Hedayatfar A; Urzua C; Papasavvas I
Eye (Lond); 2022 Jan; 36(1):29-43. PubMed ID: 34145419
[TBL] [Abstract][Full Text] [Related]
3. Vogt-Koyanagi-Harada Disease and Birdshot Retinochoroidopathy, Similarities and Differences: A Glimpse into the Clinicopathology of Stromal Choroiditis, a Perspective and a Review.
Elahi S; Herbort CP
Klin Monbl Augenheilkd; 2019 Apr; 236(4):492-510. PubMed ID: 30891715
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
5. Choroidal Vascularity Index in Vogt-Koyanagi-Harada Disease: An EDI-OCT Derived Tool for Monitoring Disease Progression.
Agrawal R; Li LK; Nakhate V; Khandelwal N; Mahendradas P
Transl Vis Sci Technol; 2016 Jul; 5(4):7. PubMed ID: 27525196
[TBL] [Abstract][Full Text] [Related]
6. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease.
Herbort CP; Abu El Asrar AM; Takeuchi M; Pavésio CE; Couto C; Hedayatfar A; Maruyama K; Rao X; Silpa-Archa S; Somkijrungroj T
Int Ophthalmol; 2019 Jun; 39(6):1419-1425. PubMed ID: 29948499
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series.
Elahi S; Gillmann K; Gasc A; Jeannin B; Herbort CP
J Curr Ophthalmol; 2019 Jun; 31(2):180-187. PubMed ID: 31317097
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging.
Aggarwal K; Agarwal A; Deokar A; Mahajan S; Singh R; Bansal R; Sharma A; Dogra MR; Gupta V;
J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):3. PubMed ID: 28091938
[TBL] [Abstract][Full Text] [Related]
9. Enhanced depth imaging optical coherence tomography features of two types of Vogt-Koyanagi-Harada disease: fuzzy or lost pattern of the choroidal vasculature is of diagnostic value.
Liu X; Wang S; An Y; Zhang H
Front Med (Lausanne); 2024; 11():1339609. PubMed ID: 38721348
[TBL] [Abstract][Full Text] [Related]
10. Delayed-onset unilateral Vogt-Koyanagi-Harada syndrome: a multimodal imaging appraisal.
Verma S; Thakur H; Azad SV; Kumar V
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33568408
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.
Herbort CP; Abu El Asrar AM; Yamamoto JH; Pavésio CE; Gupta V; Khairallah M; Tugal-Tutkun I; Soheilian M; Takeuchi M; Papadia M
Int Ophthalmol; 2017 Dec; 37(6):1383-1395. PubMed ID: 27844182
[TBL] [Abstract][Full Text] [Related]
12. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease.
Jap A; Chee SP
Br J Ophthalmol; 2017 Feb; 101(2):186-189. PubMed ID: 27048179
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
14. Vogt-Koyanagi-Harada is a Curable Autoimmune Disease: Early Diagnosis and Immediate Dual Steroidal and Non-Steroidal Immunosuppression are Crucial Prerequisites.
Papasavvas I; Tugal-Tutkun I; Herbort CP
J Curr Ophthalmol; 2020; 32(4):310-314. PubMed ID: 33553831
[TBL] [Abstract][Full Text] [Related]
15. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M
Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
[TBL] [Abstract][Full Text] [Related]
16. The Role of Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt-Koyanagi-Harada Disease.
Aggarwal K; Agarwal A; Mahajan S; Invernizzi A; Mandadi SKR; Singh R; Bansal R; Dogra MR; Gupta V;
Ocul Immunol Inflamm; 2018; 26(1):142-153. PubMed ID: 27440118
[TBL] [Abstract][Full Text] [Related]
17. Role of optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
Erba S; Govetto A; Scialdone A; Casalino G
GMS Ophthalmol Cases; 2021; 11():Doc06. PubMed ID: 33796433
[TBL] [Abstract][Full Text] [Related]
18. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease.
Fardeau C; Tran TH; Gharbi B; Cassoux N; Bodaghi B; LeHoang P
Int Ophthalmol; 2007; 27(2-3):163-72. PubMed ID: 17273903
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disease.
Abouammoh MA; Gupta V; Hemachandran S; Herbort CP; Abu El-Asrar AM
Acta Ophthalmol; 2016 Sep; 94(6):573-8. PubMed ID: 26823203
[TBL] [Abstract][Full Text] [Related]
20. Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.
Takemoto Y; Namba K; Mizuuchi K; Iwata D; Uno T; Ohno S; Hirooka K; Hashimoto Y; Saito W; Sugiyama K; Ishida S
Acta Ophthalmol; 2016 Nov; 94(7):e629-e636. PubMed ID: 27079805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
